| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9922 |
| Human Intestinal Absorption | HIA+ | 0.9875 |
| Caco-2 Permeability | Caco2+ | 0.6560 |
| P-glycoprotein Substrate | Substrate | 0.7677 |
| P-glycoprotein Inhibitor | Inhibitor | 0.8563 |
| Inhibitor | 0.5654 |
| Renal Organic Cation Transporter | Inhibitor | 0.5403 |
| Distribution |
| Subcellular localization | Lysosome | 0.5072 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7628 |
| CYP450 2D6 Substrate | Non-substrate | 0.6176 |
| CYP450 3A4 Substrate | Substrate | 0.6719 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.6350 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.6916 |
| CYP450 2D6 Inhibitor | Inhibitor | 0.7032 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.7919 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8409 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.8763 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9677 |
| Inhibitor | 0.7770 |
| AMES Toxicity | Non AMES toxic | 0.7265 |
| Carcinogens | Non-carcinogens | 0.8291 |
| Fish Toxicity | High FHMT | 0.8112 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9596 |
| Honey Bee Toxicity | Low HBT | 0.8676 |
| Biodegradation | Not ready biodegradable | 0.9970 |
| Acute Oral Toxicity | III | 0.6319 |
| Carcinogenicity (Three-class) | Non-required | 0.6678 |